FMXIN002 in Patients at Risk of Anaphylaxis
Trial details
- Registry ID
- NCT07045701
- Drugs studied
- Adrenalin 0.5mg Injectable Product, Epinephrine 4mg nasal powder spray
TrialRedline tracks 1 clinical trial sponsored by Nasus Pharma: 1 Phase 2 / 3.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| FMXIN002 in Patients at Risk of AnaphylaxisNCT07045701 | Adrenalin 0.5mg Injectable Product, Epinephrine 4mg nasal powder spray | Enrolling by invitation | 2026-06-12Estimated |
Names as written in the registry records.